Biostax Corp. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/82df156a-3624-4bcb-98ef-e3532dcb375f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-1.5M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014710 |
| FY 2022 | $-1.2M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-011692 |
| FY 2021 | $-738.2k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007249 |
| FY 2020 | $-887.0k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008834 |
| FY 2019 | $-2.8M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-008717 |
| FY 2018 | $-4.1M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-005481 |
| FY 2017 | $-5.9M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-004485 |
| FY 2016 | $-14.3M | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003099 |
| FY 2015 | $-15.8M | 2015-01-01 – 2015-12-31 | evidence 0001493152-16-008400 |
| FY 2014 | $-45.3M | 2014-01-01 – 2014-12-31 | evidence 0001354488-15-001524 |
| FY 2013 | $-96.0M | 2013-01-01 – 2013-12-31 | evidence 0001354488-14-001571 |
| FY 2012 | $-153.1M | 2012-01-01 – 2012-12-31 | evidence 0001354488-14-001571 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).